These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1444658)

  • 1. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
    Bedenić B; Zagar Z
    J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase inhibitors and Acinetobacter spp.
    Eng RH; Smith SM; Cherubin CE
    J Antimicrob Chemother; 1990 Sep; 26(3):449-51. PubMed ID: 2172200
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
    Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
    Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
    Mégraud F; Gavinet A
    Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
    Appelbaum PC; Spangler SK; Shiman R; Jacobs MR
    Antimicrob Agents Chemother; 1992 May; 36(5):1140-3. PubMed ID: 1324639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
    Aguilar L; Martín M; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 12. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
    Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
    Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of amikacin and amoxicillin-clavulanic acid against Mycobacterium tuberculosis.
    Tamás F
    Chest; 1993 Jul; 104(1):328. PubMed ID: 8325113
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio.
    Thomson CJ; Miles RS; Amyes SG
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2591-2. PubMed ID: 8585755
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA; Vanderpool L; Wesselman J
    J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM; Tullio V; Paizis G; Carlone NA
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of sensitivity of Mycobacterium spp. to combinations of clavulanic acid & penicillins with certain antitubercular agents.
    Bhattacharya CP; Charkrabarty AN; Dastidar SG
    Indian J Med Res; 1988 Aug; 88():118-23. PubMed ID: 3198169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.